Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$468M |
| 2 |
Johnson & Johnson
JNJ
|
+$440M |
| 3 |
IBM
IBM
|
+$355M |
| 4 |
Booking.com
BKNG
|
+$332M |
| 5 |
RAI
Reynolds American Inc
RAI
|
+$331M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
LLTC
Linear Technology Corp
LLTC
|
+$482M |
| 2 |
Walt Disney
DIS
|
+$247M |
| 3 |
Visa
V
|
+$219M |
| 4 |
Deere & Co
DE
|
+$200M |
| 5 |
Johnson Controls International
JCI
|
+$179M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.02% |
| 2 | Technology | 13.31% |
| 3 | Financials | 12.25% |
| 4 | Industrials | 9.65% |
| 5 | Consumer Staples | 9.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
401
Gartner
IT
$11.4B
| $43.5M | 0.06% |
402,900
+229,000
| +132% | +$23.6M |
|
402
Global Payments
GPN
$22.4B
| $43.4M | 0.06% |
538,045
-664,400
| -55% | -$52.1M |
|
403
Stanley Black & Decker
SWK
$15.4B
| $43.3M | 0.06% |
325,862
-211,100
| -39% | -$26.5M |
|
404
Rayonier Advanced Materials
RYAM
$579M
| $42.9M | 0.06% |
3,191,300
-4,700
| -0.1% | -$66K |
|
|
WFT
405
DELISTED
Weatherford International plc
WFT
| $42.9M | 0.06% |
+6,449,230
| New | +$37.8M |
|
406
Dell
DELL
$299B
| $42.7M | 0.06% |
+2,372,048
| New | +$41.4M |
|
|
ISBC
407
DELISTED
Investors Bancorp, Inc.
ISBC
| $42.6M | 0.06% |
2,962,725
+94,238
| +3% | +$1.35M |
|
408
Medifast
MED
$131M
| $42.3M | 0.06% |
954,000
+2,500
| +0.3% | +$108K |
|
409
Digital Realty Trust
DLR
$72.8B
| $42.2M | 0.06% |
397,100
+124,300
| +46% | +$13.1M |
|
410
Verisk Analytics
VRSK
$23.6B
| $42.2M | 0.06% |
519,700
+263,300
| +103% | +$21.6M |
|
411
GE Aerospace
GE
$380B
| $42M | 0.06% |
+294,103
| New | +$42.6M |
|
|
GRMN
412
Garmin
GRMN
$59.7B
| $41.9M | 0.06% |
820,142
+621,665
| +313% | +$31.3M |
|
413
Royal Caribbean
RCL
$82.3B
| $41.9M | 0.06% |
427,200
-87,600
| -17% | -$8.19M |
|
414
Stellantis
STLA
$20.1B
| $41.7M | 0.06% |
3,824,798
+740,711
| +24% | +$7.97M |
|
415
Etsy
ETSY
$7.26B
| $41.6M | 0.06% |
3,909,100
-91,900
| -2% | -$1.08M |
|
416
Estee Lauder
EL
$32B
| $41.3M | 0.06% |
487,100
-1,605,600
| -77% | -$133M |
|
417
Kulicke & Soffa
KLIC
$4.95B
| $41.2M | 0.06% |
2,029,728
-465,700
| -19% | -$8.95M |
|
418
Perdoceo Education
PRDO
$1.92B
| $41.1M | 0.06% |
4,727,962
+453,500
| +11% | +$4.17M |
|
419
InterDigital
IDCC
$8.96B
| $41.1M | 0.06% |
475,700
-42,400
| -8% | -$3.81M |
|
|
IPHS
420
DELISTED
Innophos Holdings, Inc.
IPHS
| $41M | 0.06% |
759,021
+75,721
| +11% | +$3.91M |
|
421
Hanmi Financial
HAFC
$954M
| $40.9M | 0.06% |
1,329,957
-39,400
| -3% | -$1.3M |
|
422
Everest Group
EG
$14.1B
| $40.9M | 0.06% |
174,900
+5,200
| +3% | +$1.19M |
|
423
Nasdaq
NDAQ
$53.3B
| $40.8M | 0.06% |
1,763,700
-118,800
| -6% | -$2.76M |
|
424
Gold Fields
GFI
$36.8B
| $40.8M | 0.06% |
11,546,000
-5,206,500
| -31% | -$17.6M |
|
|
GOOD
425
Gladstone Commercial Corp
GOOD
$628M
| $40.7M | 0.06% |
1,971,200
+236,000
| +14% | +$4.72M |
|
Similar funds
Jim Simons's Q1 2017 Portfolio in Review
As of Q1 2017, Jim Simons held 3,652 positions worth $71.6B, up 13% from $63.2B the previous quarter. Its ten largest holdings account for 7.9% of the portfolio.
Jim Simons deployed $5.19B of net new capital in Q1 2017, opening 433 new positions and adding to 1,585 existing holdings. Its largest new stake was Merck: 7,716,460 shares worth $468M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 12% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Walt Disney, an estimated $247M trimmed.
- Jim Simons's largest Q1 2017 buy was Merck: 7,716,460 shares worth $468M.
- Jim Simons added most to Johnson & Johnson in Q1 2017, an estimated $440M increase.
- Jim Simons's biggest Q1 2017 reduction was Walt Disney, cutting an estimated $247M.
- Jim Simons fully exited Linear Technology Corp in Q1 2017, selling an estimated $482M.
- Jim Simons's ten largest holdings make up 7.9% of its $71.6B portfolio in Q1 2017.
- Jim Simons opened 433 new positions and closed 462 in Q1 2017.
- Jim Simons's portfolio value rose 13% quarter-over-quarter to $71.6B.
Based on Renaissance Technologies's 13F filing for Q1 2017, filed 12 May 2017.